ALPEX PHARMA
YOUR SWISS PARTNER
IN DEVELOPEMENT AND MANUFACTURING OF
PHARMACEUTICAL AND NUTRITIONAL PRODUCTS
Sustained release
Sustained Release Technology Overview
Oral dosage form;
Hydrophilic-Hydrophobic matrix approach;
Incorporation of up to 600 mg of API on 1500 mg embossed tablet possible;
Duration of release up to 24 hours;